ReviewCancers2020

Emerging Targeted Therapies for HER2 Positive Gastric Cancer That Can Overcome Trastuzumab Resistance.

Seiichiro Mitani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.